James Fang, MD
Dr. Fang graduated summa cum laude from Duke University and then from Duke University School of Medicine. He did his internal medicine residency and chief residency at the Johns Hopkins Hospital. He completed both Cardiovascular Medicine and Heart Failure/Transplant fellowships at the Brigham and Women’s Hospital in 1997. He served on the faculty of the Brigham and Women’s Hospital/Harvard Medical School between 1997 and 2006 where he was Associate Professor of Medicine, Director of the Cardiovascular Fellowship Training Program, and Medical Director of Heart Transplantation and Circulatory Assistance. In August of 2006, he moved to University Hospitals Case Medical Center where he was Professor of Medicine, Associate Chief for Clinical Affairs, and the Medical Director of the Heart Failure, Transplant, and Mechanical Circulatory Support program. In April of 2013, he moved to Utah to become the Chief of the Cardiovascular Medicine Division at the University of Utah School of Medicine. He holds the John and June B. Hartman Presidential Endowed Chair in Cardiovascular Medicine and also serves as the Executive Director of the Cardiovascular Service Line.
Dr. Fang has won multiple awards for his teaching skills at the local and national levels and is regularly listed in the Best Doctors in America. Most recently he was awarded the American Heart Associate Laennec Master Clinician Award (2014). His academic interests include coronary artery disease of the transplanted heart, heart failure with preserved ejection fraction, sleep disturbances in heart failure, and ventricular assist devices. His published work includes book chapters in major CV textbooks as well as original research and reviews in the field of heart transplantation and heart failure in such journals as The Lancet, American Journal of Cardiology, Circulation, Journal of American College of Cardiology, and Journal of Heart and Lung Transplantation. He has been an invited editorialist for the New England Journal of Medicine, Circulation, Circulation Research, and the Journal of American College of Cardiology. He serves on various national committees including the HFSA heart failure guideline and board review committees, the AHA/ACC STEMI guideline writing group, and the DSMB for the NIH Cardiac Surgery Network. His heart failure sections at both the University Hospitals Case Medical Center and the University of Utah have been part of the NIH Heart Failure Clinical Trials Consortium. The University of Utah heart failure group was recently awarded one of four AHA HF network four-year grants. In 2014 he was elected to the Association of University Cardiologists. In 2017, he will serve as one of the primary chairs for the planning committee of the HFSA Annual Scientific Sessions.
Lillian Khor, MD
Lillian Khor is Malaysian by nationality and received a foreign medical degree, M.B.BCh., BAO degree (equivalent to M.D.) at the Royal College of Surgeons in Ireland, which is part of the National University of Ireland in 1997. She moved to the United States in 2000 and completed her Internal Medicine residency and Cardiology at the University of Utah from 2000-2007. During her training, she was Chief Medical Resident of the Coronary Care Unit at LDS Hospital for 6 months and Chief Cardiology Fellow from 2005-2006. Her professional training since graduation was initially based at the Veterans Affairs Medical Center (VAMC), where she was Coronary Care and Telemetry Unit Director, Cardiology Clinic Medical Director, Cardiology Fellowship site Director, and Medical Residency and Student Clerkships Director. Since 9/2010, Dr. Khor has been working part-time at both the VAMC and the University of Utah Hospital. She is the Medical Director of Preventive Cardiology and Cardiac Rehabilitation at the University of Utah Health and Medical Director of center and home-based Cardiac Rehabilitation at the VAMC.
Dr. Khor’s clinical interests are in secondary prevention of cardiovascular events and obesity-associated heart failure. She collaborates clinically with the bariatric service and her clinical niche is in peri-operative optimization of obese patients with heart failure. As a clinician, her other research interests include outcomes research in cardiac rehabilitation and obesity associated heart failure with preserved ejection fraction. She has published on gender and age-related differences in the prognostic value of a biomarker (C-reactive protein) in patients with established coronary artery disease. She is also board certified in echocardiography and is interested echocardiographic markers of cardiopulmonary hemodynamics in obesity. Dr. Khor is also dedicated to primordial cardiovascular risk prevention and reduction and volunteered for the American Heart Association (AHA) as President of the Utah Board of Directors from 2010-2014.
Dr. Khor and her Irish husband, whom she met in medical school, have been married for over 17 years and have three children. As a result of a nomadic childhood, Dr. Khor is a native English-speaker who is also fluent in Portuguese, French, and Spanish. Her biggest shame is that she can only say potty words in Chinese and Malay. Her hobbies include growing saffron and scape, cooking and eating, skiing, biking, and supervising the husbandry of backyard chickens and bees. She is passionate about practicing a healthy lifestyle in the beautiful out-doors, sharing and preserving it with her family and friends.